A Director at Aduro BioTech is Exercising Options

Yesterday it was reported that a Director at Aduro BioTech (ADRO – Research Report), Ross Haghighat, exercised options to buy 55,539 ADRO shares at $0.63 a share, for a total transaction value More »

Chardan Capital Sticks to Its Hold Rating for IVERIC bio Inc (ISEE)

Chardan Capital analyst Gbola Amusa reiterated a Hold rating on IVERIC bio Inc (ISEE – Research Report) yesterday and set a price target of $1.25. The company’s shares closed last Monday at More »